
Abdel Omri
Lipid-Based Drug & Vaccine Delivery Systems
Liposomes are one of the most versatile biochemical tools. They are microscopic, spherical closed vesicles composed of one or more lipid bilayer that form when phospholipids are hydrated. Hydrophilic molecules can be incorporated into the aqueous compartment and lipophilic molecules can be encapsulated in the lipid bilayers. Liposomes by themselves are considered nonimmunogenic, biodegradable and nontoxic. They have been utilized in numerous biomedical applications including gene therapy, for delivery of drugs and vaccines, cancer imaging agents and cosmetics. Liposomes have the capability to incorporate selected bioactive biologicals and adjuvant molecules and potentiate their efficacy and minimize their toxicity. They do this by beneficially altering the biodistribution and pharmacokinetics of the molecule in the body following its administration through various routes of delivery.
My research program is centered on the design, formulation, development and characterization of drug and vaccine delivery systems; particularly those based on liposomes. A special focus on the site-specific targeting controlled release, drug resistance, pharmacokinetic, pharmacodynamic, metabolism and toxicity of free and liposome-encapsulated biological active agents.
Liposomal Delivery of Antimicrobial Agents toward Resistant Bacteria.
Liposomal Delivery of Antioxidants and Oxidative Stress
Liposomal Delivery of Antisense Oligonucleotides
Liposomal Formulations of Drugs and Vaccines for Oral Administration
Liposomes are one of the most versatile biochemical tools. They are microscopic, spherical closed vesicles composed of one or more lipid bilayer that form when phospholipids are hydrated. Hydrophilic molecules can be incorporated into the aqueous compartment and lipophilic molecules can be encapsulated in the lipid bilayers. Liposomes by themselves are considered nonimmunogenic, biodegradable and nontoxic. They have been utilized in numerous biomedical applications including gene therapy, for delivery of drugs and vaccines, cancer imaging agents and cosmetics. Liposomes have the capability to incorporate selected bioactive biologicals and adjuvant molecules and potentiate their efficacy and minimize their toxicity. They do this by beneficially altering the biodistribution and pharmacokinetics of the molecule in the body following its administration through various routes of delivery.
My research program is centered on the design, formulation, development and characterization of drug and vaccine delivery systems; particularly those based on liposomes. A special focus on the site-specific targeting controlled release, drug resistance, pharmacokinetic, pharmacodynamic, metabolism and toxicity of free and liposome-encapsulated biological active agents.
Liposomal Delivery of Antimicrobial Agents toward Resistant Bacteria.
Liposomal Delivery of Antioxidants and Oxidative Stress
Liposomal Delivery of Antisense Oligonucleotides
Liposomal Formulations of Drugs and Vaccines for Oral Administration
less
Related Authors
James Elkins
School of the Art Institute of Chicago
Asha Vijayan
Amrita Vishwa Vidyapeetham
Dr.Mahmoud Lotfy
Minufiya University
Nassim Tahouni
University of Tehran
Michael J. Gonzalez
Universidad de Puerto Rico Rio
Dr.Yousery Sherif
Mansoura University
Hanaa Ahmed
Animal Health Research Institute
Irina Kolesnik
Moscow State University
Prof. Tofazzal Islam
Bangabandhu Sheikh Mujibur Rahman Agricultural University
Kenneth Vecchio
University of California, San Diego
InterestsView All (9)
Uploads
Papers by Abdel Omri